Insilico Medicine and Human Longevity Partner on AI Foundation Model for Longevity Science

According to Jin10, Insilico Medicine and Human Life Foundation Models, a subsidiary of Human Longevity, announced a multi-million dollar strategic partnership on May 27 to jointly develop the industry's first AI foundation model specifically designed for human longevity research. The model aims to accelerate breakthroughs in early detection of aging-related diseases, predictive health risk modeling, AI-driven drug discovery for longevity therapeutics, and personalized intervention strategies.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments